Recent breakthroughs in senolytic and senomorphic therapies, including polyunsaturated lipids inducing ferroptosis, are advancing clinical trials for age-related diseases, with a focus on safety and b...
Exploring recent advances in senolytic and senomorphic therapies, including dasatinib-quercetin and immune-based approaches, to combat age-related diseases like Alzheimer’s and sarcopenia. New t...
Recent studies link IGFBP7 from senescent cells to reduced exercise benefits in older adults, with senolytic therapies offering new avenues for enhanced fitness and healthy aging interventions. IGFBP7...
Emerging research links aging oral microbiome with senescent cells to amplify systemic inflammation, driving diseases like Alzheimer’s and offering new intervention targets such as probiotics an...
A Nature Aging study shows mitochondrial stress enhances senolytic drugs like navitoclax, improving senescent cell removal by 40% with metabolic interventions. New research reveals mitochondrial stres...
This article explores how senotherapeutics target senescent cells in the brain to reduce neuroinflammation and improve cognition, based on recent preclinical studies and emerging clinical trials. Emer...
In 2025, aging research sees major advancements with senolytics and mitochondrial therapies, backed by clinical trials and shifting medical attitudes towards treating aging as a condition. Recent tria...
Explore the science of immunosenescence and evidence-based strategies to reverse age-related immune decline, including nutrition, exercise, and emerging therapies. Immunosenescence, the age-related de...
Explore the latest research on longevity, focusing on lifestyle interventions like caloric restriction, exercise, stress reduction, sleep, and telomere health. Discover how simple lifestyle changes ca...
